D
Sell
2/27/2025Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D- from E+ on 2/27/2025 due to an increase in the volatility index.
E
Sell
1/30/2025Downgrade
Legend Biotech Corporation (LEGN) was downgraded to E+ from D- on 1/30/2025 due to a substantial decline in the total return index, growth index and volatility index. Operating cash flow declined 4,492.49% from -$1.65M to -$75.82M, earnings per share declined from -$0.2 to -$1.3676, and EBIT declined 67.63% from -$41.97M to -$70.36M.
D
Sell
3/14/2023Downgrade
Legend Biotech Corporation (LEGN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/23/2023Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D from D- on 2/23/2023 due to an increase in the volatility index and valuation index.
D
Sell
2/8/2023Downgrade
Legend Biotech Corporation (LEGN) was downgraded to D- from D on 2/8/2023 due to a decline in the solvency index and valuation index. Debt to equity increased from 0.26 to 0.29.
D
Sell
5/16/2022Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
Legend Biotech Corporation (LEGN) was downgraded to E+ from D on 5/13/2022 due to a decline in the total return index and volatility index.
D
Sell
5/4/2022Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D from E+ on 5/4/2022 due to an increase in the total return index and volatility index.
E
Sell
5/1/2022Downgrade
Legend Biotech Corporation (LEGN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
Legend Biotech Corporation (LEGN) was downgraded to E+ from D on 4/20/2022 due to a large decline in the total return index and volatility index.
D
Sell
11/23/2021Upgraded
Legend Biotech Corporation (LEGN) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Legend Biotech Corporation (LEGN) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
8/25/2021None
Legend Biotech Corporation (LEGN) was downgraded to D from U on 08/25/2021.
